426 - CD3+ Graft Cell Count Predicts Chronic Gvhd Incidence in Haploidentical Allogeneic Transplantation Using Post-Transplant Cyclophosphamide.

MLA

Mussetti, Alberto, et al. “426 - CD3+ Graft Cell Count Predicts Chronic Gvhd Incidence in Haploidentical Allogeneic Transplantation Using Post-Transplant Cyclophosphamide.” Biology of Blood & Marrow Transplantation, vol. 24, Mar. 2018, p. S297. EBSCOhost, https://doi.org/10.1016/j.bbmt.2017.12.338.

APA

Mussetti, A., De Philippis, C., Carniti, C., Bastos-Oreiro, M., Gayoso, J., Cieri, N., Ciceri, F., Greco, R., Peccatori, J., Patriarca, F., Mariotti, J., Castagna, L., & Corradini, P. (2018). 426 - CD3+ Graft Cell Count Predicts Chronic Gvhd Incidence in Haploidentical Allogeneic Transplantation Using Post-Transplant Cyclophosphamide. Biology of Blood & Marrow Transplantation, 24, S297. https://doi.org/10.1016/j.bbmt.2017.12.338

Chicago

Mussetti, Alberto, Chiara De Philippis, Cristiana Carniti, Mariana Bastos-Oreiro, Jorge Gayoso, Nicoletta Cieri, Fabio Ciceri, et al. 2018. “426 - CD3+ Graft Cell Count Predicts Chronic Gvhd Incidence in Haploidentical Allogeneic Transplantation Using Post-Transplant Cyclophosphamide.” Biology of Blood & Marrow Transplantation 24 (March): S297. doi:10.1016/j.bbmt.2017.12.338.